The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Coverdine 5 mg/1.25 mg/5 mg film-coated tablets

Lexon Pharmaceuticals (Ireland) LimitedPPA23176/022/001

Main Information

Trade NameCoverdine 5 mg/1.25 mg/5 mg film-coated tablets
Active SubstancesAmlodipine
Perindopril arginine
Dosage FormFilm-coated tablet
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/022/001

Group Information

ATC CodeC09BX ACE inhibitors, other combinations
C09BX01 perindopril, amlodipine and indapamide


License statusAuthorised
Licence Issued31/08/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0568/024/002.
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back